Evolution of Drug Discovery: From Chemistry to Biologics and Machine Learning

This chapter tracks the speaker's journey through the evolution of drug discovery, from the focus on chemistry to the rising importance of biologics and machine learning in developing new medicines. It discusses the skepticism towards antibody drugs, the challenges of integrating AI and machine learning in pharmaceutical companies, and the transition from traditional to modern drug discovery approaches.